Fact Sheet
Sexually active women younger than 25 years or women with new or multiple sex partners, or a sex partner who has an STD should be tested every year.
Antibiotic Resistance
Gonorrhea has progressively developed resistance to the antibiotic drugs prescribed for treatment.
Highlights
AR Investment Map This interactive tool shows CDC’s key investments to combat antibiotic resistance (AR), including resistant gonorrhea, across the nation.
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014 MMWR July 14, 2016
Antimicrobial-Resistant Gonorrhea Infographics(https://www.cdc.gov/std/products/infographics.htm) (July 14, 2016)
De-Duplication Guidance for Gonorrhea and Chlamydia Laboratory Reports(https://www.cdc.gov/std/laboratory/de-duplication-guidance-june2016.pdf) - This document contains background and guidance on the timeframe that jurisdictions should use to de-duplicate their gonorrhea and chlamydia laboratory reports before reporting these cases to CDC.(June 17, 3016)
2015 STD Treatment Guidelines - Gonococcal Infections(https://www.cdc.gov/std/tg2015/gonorrhea.htm) - Includes alternative treatment regimens and updated testing recommendations for gonococcal infections, as well as diagnosis, prevention, and special considerations. (June 4, 2015)
STD Surveillance Case Definitions(https://www.cdc.gov/std/stats/casedefinitions-2014.pdf) - Includes updated definitions for Gonorrhea and Syphilis effective January 1, 2014 (December 10, 2013)
Changes to Gonorrhea and Syphilis Case Definitions: Program Impact(https://www.cdc.gov/std/stats/casedef-programimpact-2014.pdf) (January 16, 2014)
- Page last reviewed: December 9, 2016
- Page last updated: January 12, 2017
- Content source: